REGN

NASDAQ · Equity

Regeneron Pharmaceuticals Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
614.780000
Fair value
783.082316
Expectation
Undecided 50.77%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
614.78
12-Week Change
-17.45%
Trend Signal
Inactive
Expectation
Undecided 50.77%
Signal Weeks
8 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-24.26
Market Dynamics
-1.06

Over the latest 12 completed weeks ending 2026-05-29, REGN fell 17.45%, moving from 744.69 to 614.78. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 8 of the last 12 weeks. Relative Strength is -24.26 and has softened across the 12-week window. Market Dynamics is -1.06 on the latest week. Expectation is undecided at 50.77%.